SecBot SecBot
SECBOTREPLAY Home › Report › CABA

CABA · T. Rowe Price stake 13.1%

Cabaletta Bio, Inc. · SC 13G/A filed Nov 6, 2026 at 11:07 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 6, 2026 at 11:07 ET

T. Rowe Price Investment Management filed an amended Schedule 13G for Cabaletta Bio, reporting beneficial ownership of 28,138,417 shares (13.1% of common stock) as of October 31, 2026, up from 17,250,098 shares (8.0%) as of September 30, 2026. This is a routine passive stake increase by a large asset manager and has no material directional impact.

  • T. Rowe Price Investment Management reported beneficial ownership of 28,138,417 shares of Cabaletta Bio common stock as of October 31, 2026.
  • The stake represents 13.1% of the outstanding common stock.
  • This is an amendment to a Schedule 13G, indicating passive investment intent.
  • The filing was made pursuant to Rule 13d-1(b).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access